Skip to main content
SELLAS Life Sciences Group, Inc. logo

SELLAS Life Sciences Group, Inc. — Investor Relations & Filings

Ticker · SLS ISIN · US81642T2096 LEI · 549300VZIH50VYURLQ98 US Manufacturing
Open in API
Filings indexed 1,071 across all filing types
Latest filing 2012-06-19 Director's Dealing
Country US United States of America
Listing US SLS

About SELLAS Life Sciences Group, Inc.

https://www.sellaslifesciences.com/

SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's core activity involves advancing its pipeline of cancer immunotherapies, which are designed to utilize the patient's immune system to combat various malignancies. Its development programs aim to address significant unmet medical needs in oncology by creating new treatment options for cancer patients.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2012-06-19 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated June 15, 2012, reporting the submission of matters to a vote of security holders at the company's Annual Meeting of Stockholders. It details the proposals voted on and the voting results. The content focuses on the official results from shareholder votes at the Annual Meeting. The document length is 4328 characters, which is relatively short but contains detailed voting results, not just an announcement of a report. The key content matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Therefore, the correct classification is DVA with high confidence.
2012-06-18 English
FORM S-3
Capital/Financing Update Classification · 100% confidence The document is a Post-Effective Amendment No. 1 to a Form S-3 Registration Statement filed with the SEC. It discusses deregistration of securities under a previous registration statement and references Rule 415 of the Securities Act of 1933. Form S-3 is a registration statement used for securities offerings, which falls under capital raising and financing activities. The document is not a financial report, earnings release, or management discussion, but rather an update related to the company's capital structure and securities registration. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a mere announcement but a substantive filing related to capital.
2012-05-31 English
FORM 8-K
Legal Proceedings Report Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content describes the dismissal of lawsuits related to warrant disputes and settlement agreements, which is a legal proceeding update. There are no financial statements or detailed financial data, so it is not an Annual Report, Earnings Release, or Interim Report. The document is not a report publication announcement or certification. The primary content relates to legal matters and settlements, fitting the category of Legal Proceedings Report.
2012-05-30 English
Regulatory Filings 2012
Regulatory Filings
2012-05-30 English
PROSPECTUS SUPPLIMENT
Capital/Financing Update Classification · 95% confidence The document is titled 'Prospectus Supplement' and is filed pursuant to Rule 424(b)(3), which is a SEC rule related to prospectus supplements for securities offerings. The content discusses details about selling stockholders and shares being offered, which is typical for capital raising or financing activities. The document length is short (1997 characters), and it is not a full financial report but rather an update or supplement to a prospectus. Therefore, this document fits the category of Capital/Financing Update (CAP).
2012-05-25 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.